Hypometabolism and atrophy patterns associated with Niemann-Pick type C

Area of Science:

• Neuroimaging
• Neurology
• Genetics

Background:

• Niemann-Pick disease type C (NP-C) is a rare genetic disorder causing progressive neurological decline.
• Early diagnosis is crucial for treatment with miglustat to slow disease progression.
• Current neuroimaging standards include MRI.

Purpose of the Study:

• To evaluate [18F]FDG PET as an adjunct diagnostic tool for NP-C.
• To compare the sensitivity of [18F]FDG PET and MRI in detecting NP-C related neurodegeneration.
• To assess the role of [18F]FDG PET in monitoring NP-C disease progression.

Main Methods:

• Cross-sectional and longitudinal study of 22 NP-C patients.
• Utilized MRI, [18F]FDG PET, and clinical assessments.
• Analyzed group-level and single-subject imaging data.

Main Results:

• [18F]FDG PET revealed extensive hypometabolism in the cerebellum, thalamus, and cingulate cortex, often in regions without apparent atrophy on MRI.
• [18F]FDG PET demonstrated higher effect sizes than MRI, suggesting greater sensitivity.
• Longitudinal analysis showed progressive cerebellar hypometabolism, with a trend towards slower progression in patients treated with miglustat.

Conclusions:

• A specific hypometabolism pattern in NP-C was identified using [18F]FDG PET.
• [18F]FDG PET may be a valuable tool for NP-C diagnosis and disease progression studies.
• The findings suggest [18F]FDG PET could differentiate NP-C from other neurodegenerative conditions.